CurrentUnitedHealthcarePolicy CS107.AE

Rhinoplasty and Other Nasal Procedures

Defines medical necessity criteria for nasal valve procedures/repair of nasal vestibular stenosis or alar collapse, rhinophyma excision, rhinoplasty (congenital, primary, revision, tip), nasal polypectomy (refer to InterQual), and lists unproven procedures and applicable billing codes. Applies broadly except for specified state-specific policies.

Policy Summary

PayerUnitedHealthcare

PolicyRhinoplasty and Other Nasal Procedures

Policy CodePolicy CS107.AE

Change TypeRevisions and template update (state application changes; codes updated)

Effective DateJun 1, 2025

Next Review Date

Key ActionPhotos must clearly document dynamic collapse or anatomic deformities as primary cause of Mechanical Nasal Airway Obstruction and be consistent with clinical exam for coverage determination

POLICY UPDATE CHANGES

Added language indicating policy does not apply to Idaho and Kansas; refer to state-specific policy versions.

Added language clarifying medical records documentation may be required to assess clinical criteria for coverage.

CPT code 30999 removed from Applicable Codes.

Template Update removed content/language pertaining to the state of Louisiana.

Supporting information sections (Description of Services, Clinical Evidence, References) updated to reflect current information and prior version archived.

MultipleProcedures covered with conditions

11States with separate policies listed

Unproven procedures listed

ModerateEvidence supporting PNN ablation through 12-24 months

LimitedLong-term comparative data across modalities

Coverage Summary

Scope: This policy defines medical necessity criteria for nasal valve procedures/repair of nasal vestibular stenosis or alar collapse, rhinophyma excision, rhinoplasty (congenital, primary functional, revision, and tip), and references InterQual for nasal polypectomy. It also lists procedures considered unproven/not medically necessary (e.g., absorbable polylactic acid implants such as Latera, NSB reduction, PNN/SPG ablation, and radiofrequency treatment of nasal valves) and provides applicable CPT/HCPCS codes and device references. The policy applies broadly but excludes certain states with separate policies (see state-specific application).

Coverage overview: The policy takes a mixed coverage stance: several procedures are covered when explicit clinical criteria and documentation requirements are met (photos, examinations, validated symptom scores, prior medical therapy), while other procedures or indications lacking sufficient evidence are designated unproven or not medically necessary and may be denied or require additional review.

Key thresholds and policy dates

Effective date2025-06-01

Policy numberCS107.AE

StatusCURRENT

Conservative management duration (rhinoplasty primary/revision/tip)>= 4 weeks (includes nasal steroids or immunotherapy where appropriate)

Prolonged, persistent nasal airway obstruction (definition)>= 6 weeks of medical management (e.g., nasal steroids, antihistamines, decongestants)

Responder definitions (studies)>= 30% reduction in TNSS/rTNSS or >= 20% reduction in NOSE or >=1 severity class improvement

Medical-Necessity Criteria

Nasal valve procedures/repair of nasal vestibular stenosis or alar collapse - Medically necessary

Nasal valve procedures/repair of nasal vestibular stenosis or alar collapse are considered reconstructive and medically necessary when ALL of the following criteria are present:

ALL of the following

Prolonged, persistent obstructed nasal breathing due to internal and/or External Nasal Valve compromise;
Other causes of nasal obstruction (e.g., rhinosinusitis, allergic rhinitis, vasomotor rhinitis, nasal polyposis, adenoid hypertrophy, and/or nasopharyngeal masses) have been adequately treated with maximal therapy and nasal obstruction persists;
Nasal septal deviation and turbinate hypertrophy either:
- Are not present;
- ALL of the following

Not Covered / Unproven Procedures

Unproven / Not medically necessary procedures

The following procedures are considered unproven and not medically necessary due to insufficient evidence:

Absorbable polylactic acid nasal cartilage support implants (e.g., Latera)

Nasal septal swell body (NSB) reduction for treatment of nasal obstruction

Posterior nasal nerve or sphenopalatine ganglion ablation using any method (e.g., radiofrequency or cryoablation such as RhinAer, ClariFix) for chronic rhinitis

Radiofrequency treatment of nasal valves for nasal airway obstruction (e.g., VivAer ARC Stylus)

Procedures or devices supported mainly by small, single-arm studies, short follow-up, or heterogeneous concomitant treatments may be considered investigational or only conditionally covered. The policy notes that evidence for several newer implants and techniques is low quality with inadequate long-term comparative data, and that payers may require robust documentation and may deny coverage when high-quality, long-term comparative evidence is lacking.

Evidence Summary & Guideline Context

The evidence base shows mixed quality: randomized trials and systematic reviews exist for multiple procedures (nasal valve surgery, rhinoplasty variants, Latera implant, TCRF/VivAer, PNN ablation, and cryoablation), but many studies are small, single-arm, industry‑sponsored, or have short follow-up. Technology assessments (ECRI, Hayes) call the overall evidence very low to low quality for several devices and recommend sham‑controlled, double‑blind RCTs with longer follow‑up and head‑to‑head comparisons. Professional society positions (ASPS, AAO‑HNS, ARS) provide context supporting reconstructive nasal surgery and, in some cases, cautious endorsement of specific biomaterials or PNN ablation for selected patients.

Notable study-level evidence (highlights)

Key limitations and calls for further research

Coding

Billing Rule

Coding review risk

Prior authorization may be required. Document baseline symptom scores and the trial of prior medical therapy in the medical record. Record the specific device and procedure used. Coding review risk: ensure that the affected codes are supported by documentation of medical necessity, photos, modified Cottle maneuver findings, and description of static vs dynamic valve compromise and graft needs.

Affected codes: K200300, K190356, K221907, K161191, LRC, LYA

Provider Actions & Prior Authorization

Documentation Required

Photographic documentation required

Photographs must clearly document dynamic collapse or anatomic deformities narrowing the internal and/or external nasal valve as the main cause of the mechanical nasal airway obstruction and be consistent with the clinical exam for coverage determination.

Documentation Required

Clinical exam and maneuver documentation

Document visible collapse of the alar (lower lateral) cartilage and/or lateral nasal wall with deep inspiration, and record subjective and audible improvement in nasal airflow during a modified Cottle maneuver. The surgeon should describe whether the compromise is static or dynamic, the anatomic location (internal, external, or both), and include a clear surgical plan addressing the need for cartilage grafting if applicable.

Definitions

Term	Definition
Mechanical Nasal Airway Obstruction	Trouble breathing through the nose due to a bony or cartilaginous deformity
Prolonged, Persistent Nasal Airway Obstruction	Trouble breathing through the nose that has not responded to six weeks of medical management; elimination of drug-induced rhinitis
External Nasal Valve	Caudal septum with lower lateral cartilage, alar rim, and nostril sill contributing to external nasal valve function
Acute Rhinosinusitis (ARS)	Inflammation of the mucosa of the nose and paranasal sinuses with sudden onset symptoms up to 4 weeks
Chronic Rhinosinusitis (CRS)	Inflammatory process involving paranasal sinuses persisting longer than 12 weeks
NOSE	Nasal Obstruction Symptom Evaluation score, disease-specific patient-reported outcome
rTNSS	Reflective Total Nasal Symptom Score, used for chronic rhinitis symptom severity
TCRF	Temperature-controlled radiofrequency
RFA	Radiofrequency ablation
rTNSS / TNSS	Reflective Total Nasal Symptom Score / Total Nasal Symptom Score — validated patient-reported instruments for nasal symptoms (rhinorrhea, congestion, sneezing, itching)
NOSE Scale	Nasal Obstruction Symptom Evaluation — validated instrument to assess severity of nasal airway obstruction
Responder (studies)	Study-specific definitions: commonly ≥30% reduction in TNSS/rTNSS or ≥20% reduction in NOSE or ≥1 severity class improvement

Study Inclusion Thresholds & Responder Definitions

Thresholds (trial & policy) and examples

Conservative management durations>= 4 weeks for rhinoplasty primary/revision/tip; definition of prolonged persistent obstruction = >= 6 weeks of medical management

NOSE / NAO enrollment threshold examplesMany NAO studies enrolled severe-to-extreme NOSE (examples: baseline NOSE >=55; Yao TCRF studies used NOSE >=60)

rTNSS enrollment thresholds (PNN trials)Common trial eligibility: rTNSS >= 6 with rhinorrhea subscore 2-3 and congestion subscore 1-3; some trials used total rTNSS >=4 with subscores (Del Signore 2022)

Responder definitions used in trials>= 30% reduction in TNSS/rTNSS (PNN/cryo trials) ; >=20% reduction in NOSE or >=1 severity class improvement (TCRF/NOSE studies)

Baseline NOSE examplesExamples in literature: NOSE >=55 (San Nicolo), NOSE >=60 or >= 75-80 reported as baseline in some TCRF cohorts (Yao mean baseline ~80)

Applicable CPT/HCPCS codes referenced

Revision History

04/01/2026revisionLatest

Template Update — Removed content/language pertaining to the state of Louisiana (is_material: false).

06/01/2025revision

Application update — Added language that the Medical Policy does not apply to Idaho and Kansas; refer to state-specific policy versions (is_material: true).

06/01/2025revision

Medical Records Documentation section updated — Added language clarifying medical records documentation may be required to assess clinical criteria for coverage (is_material: true).

Policy Summary

PayerUnitedHealthcare

PolicyRhinoplasty and Other Nasal Procedures

Policy CodePolicy CS107.AE

Change TypeRevisions and template update (state application changes; codes updated)

Effective DateJun 1, 2025

Next Review Date

Key ActionPhotos must clearly document dynamic collapse or anatomic deformities as primary cause of Mechanical Nasal Airway Obstruction and be consistent with clinical exam for coverage determination

On This Page

Have been previously surgically treated; or
Are scheduled to be surgically treated at the same time as the nasal valve procedure/repair as part of the surgery plan

Documented evidence of visible collapse of the alar (lower lateral) cartilage (External Nasal Valve) and/or lateral nasal wall (internal nasal valve) with deep inspiration;

Documented evidence of subjective and audible improvement in nasal airflow during modified Cottle maneuver;

Photos clearly document either dynamic collapse of the internal and/or External Nasal Valve or anatomic deformities narrowing the internal and/or External Nasal Valve as a main cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam;

ALL of the following

The surgeon has clearly described:
ALL of the following
- Whether the nasal valve compromise is static or dynamic; and
- Whether the nasal valve compromise involves internal nasal valve, External Nasal Valve, or both; and
- A plainly stated and clear surgical plan including the need for a cartilage graft

Nasal valve procedures/repair of nasal vestibular stenosis or alar collapse - Not medically necessary

Nasal valve procedures/repair of nasal vestibular stenosis or alar collapse are not considered reconstructive and medically necessary in all other indications.

ANY of the following

All other indications not meeting the medical necessity criteria listed above.

Rhinophyma excision - Medically necessary

Rhinophyma excision is considered reconstructive and medically necessary when ALL of the following criteria are present:

ALL of the following

One of the following:
- Prolonged, persistent obstructed nasal breathing due to rhinophyma; or
- Chronic infection or bleeding unresponsive to medical management due to rhinophyma
Photos clearly document rhinophyma as the primary cause of an anatomic Mechanical Nasal Airway Obstruction or chronic infection and are consistent with the clinical exam; and
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by correcting the deformity or the proposed procedure is designed to address the chronic infection.

Rhinophyma excision - Not medically necessary

Rhinophyma excision is not considered reconstructive and medically necessary in all other indications.

ANY of the following

All other indications not meeting the medical necessity criteria listed above.

Rhinoplasty for congenital anomalies - Medically necessary

Rhinoplasty for congenital anomalies is considered reconstructive and medically necessary when the following are present:

ALL of the following

Rhinoplasty is performed for a nasal deformity associated with congenital craniofacial anomalies including but not limited to Pierre Robin, Apert syndrome, Fraser syndrome, Binder syndrome, Goldenhar syndrome, nasal dermoids, Tessier nasal cleft (most commonly no.1), or associated with a cleft lip or cleft palate

Rhinoplasty for congenital anomalies - Not medically necessary

Rhinoplasty for congenital anomalies is not considered reconstructive and medically necessary in all other indications.

ANY of the following

All other indications not meeting the criteria above.

Rhinoplasty - primary (functional) - Medically necessary

Rhinoplasty - primary is considered reconstructive and medically necessary when ALL of the following criteria are present:

ALL of the following

The indication for surgery is one of the following:
- Prolonged, persistent obstructed nasal breathing due to nasal bone and septal deviation that are the primary causes of an anatomic Mechanical Nasal Airway Obstruction; or
- Nasal fracture with nasal bone displacement severe enough to cause nasal airway obstruction; or
- Residual large cutaneous defect following resection of a malignancy or nasal trauma
The nasal airway obstruction cannot be corrected by septoplasty alone as documented in the medical record; and
Photos clearly document the nasal bone/septal deviation as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam; and
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by centralizing the nasal bony pyramid and straightening the septum; and
Nasal airway obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing); and
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Rhinoplasty - primary (functional) - Not medically necessary

Rhinoplasty - primary is not considered reconstructive and medically necessary in all other indications.

ANY of the following

All other indications not meeting the medical necessity criteria listed above.

Rhinoplasty - revision

Rhinoplasty - revision is primarily cosmetic. However, it is considered reconstructive and medically necessary when ALL of the following criteria are present:

ALL of the following

Required as treatment of a complication/residual deformity from primary surgery performed to address a Functional Impairment when a documented Functional Impairment persists due to the complication/deformity; and
Photos clearly document the secondary deformity/complication as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam; and
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by correcting the deformity or treating the complication; and
Nasal airway obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing); and
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Rhinoplasty - tip

Rhinoplasty - tip is primarily cosmetic. However, it is considered reconstructive and medically necessary when ALL of the following criteria are present:

ALL of the following

Prolonged, persistent obstructed nasal breathing due to tip drop that is the primary cause of an anatomic Mechanical Nasal Airway Obstruction; and
Photos clearly document tip drop as the primary cause of an anatomic Mechanical Nasal Airway Obstruction and are consistent with the clinical exam (acute columellar-labial angle); and
The proposed procedure is designed to correct the anatomic Mechanical Nasal Airway Obstruction and relieve the nasal airway obstruction by lifting the nasal tip; and
Nasal airway obstruction is causing significant symptoms (e.g., Chronic Rhinosinusitis, difficulty breathing); and
Obstructive symptoms persist despite conservative management for 4 weeks or greater, which includes, where appropriate, nasal steroids or immunotherapy

Rhinoplasty - tip - Not medically necessary

Rhinoplasty - tip is not considered reconstructive and medically necessary in all other indications.

ANY of the following

All other indications not meeting the medical necessity criteria listed above.

Nasal polypectomy

Nasal polypectomy is considered reconstructive and medically necessary in certain circumstances. For medical necessity clinical coverage criteria, refer to the InterQual CP: Procedures, Polypectomy, Nasal.

ALL of the following

Refer to InterQual \u00AE CP: Procedures, Polypectomy, Nasal for the clinical criteria used to determine medical necessity for nasal polypectomy; click the InterQual link or access InterQual content as part of the review process.

Documentation Required

Prior treatment documentation

Document adequate prior treatment of other causes of nasal obstruction (for example, rhinosinusitis, allergic rhinitis) and that nasal obstruction persists despite maximal therapy; include details of prior medical and surgical therapies in the record.

Documentation Required

Conservative management documentation

Document failure of conservative management before surgery. For rhinoplasty primary, revision, and tip indications, obstructive symptoms must persist despite conservative management for 4 weeks or greater (e.g., appropriate use of nasal steroids or immunotherapy). Note the policy definition also references 6 weeks for prolonged, persistent nasal airway obstruction in other contexts.

Conservative management ≥ 4 weeks for rhinoplasty indications
Prolonged/persistent obstruction definition references ≥ 6 weeks

Documentation Required

Record baseline symptom scores

Record validated baseline symptom scores to support severity and candidacy. Document NOSE, rTNSS (or TNSS), VAS, and SNOT-22 baseline scores and any study-specific eligibility thresholds used (examples in trials: baseline NOSE often ≥55 or ≥60; rTNSS thresholds such as ≥4 or ≥6; responder definitions like ≥30% rTNSS reduction or ≥20% NOSE improvement).

Record NOSE, rTNSS/TNSS, VAS, and SNOT-22 at baseline
Include study-specific thresholds (e.g., NOSE ≥55–60; rTNSS ≥4 or ≥6)
Note responder definitions used in trials (≥30% rTNSS or ≥20% NOSE)

Prior Authorization

State-specific application

This policy does not apply to certain states; providers must refer to the state-specific policy or guideline for the following states: Idaho, Indiana, Kansas, Kentucky, Nebraska, New Jersey, New Mexico, North Carolina, Ohio, Pennsylvania, and Tennessee.

Denial Risk

Risk of noncoverage for investigational indications

Procedures or devices lacking high-quality, long-term comparative evidence (for example some absorbable implants, certain NSB reduction techniques, or other novel approaches without robust RCT data) may be considered investigational or conditionally covered; such indications are at risk for noncoverage. Expect coverage review and possible denial when clinical criteria and evidence are not met.

Absorbable implants and some NSB reduction techniques have low-quality/limited long-term evidence
Providers should anticipate review and potential denial if criteria or evidence are insufficient

Documentation Required

Medical Records Documentation

Medical records documentation may be required to assess whether a member meets the clinical criteria for coverage. Documentation should demonstrate how the patient meets policy criteria (symptom scores, prior therapies, exam findings, photos, procedure/device details). Note that providing documentation does not guarantee coverage.

Records may be requested to verify clinical criteria for coverage
Documentation alone does not guarantee coverage

Prior Authorization

State/Contractual Requirements Take Precedence

Verify federal, state, and contractual benefit plan terms before requesting authorization or billing. State or contractual requirements for coverage may differ from this standard policy and take precedence in the event of a conflict.

Check plan- and state-specific coverage rules
State/contractual terms govern if they conflict with this policy

Examples: 30468 (repair with implant), 30469 (repair with TCRF), 31242/31243 (PNN RF/cryo), L8699 (prosthetic implant) — see Applicable Codes list

06/01/2025code_update

Applicable Codes updated — CPT code 30999 removed (is_material: true).

06/01/2025revision

Supporting Information updated and prior version archived (Archived previous policy version CS107.AD) (is_material: false).